High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma

NCT07014943 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Primary Central Nervous System Lymphoma (PCNSL)

Interventions

DRUG: High dose Gemcitabine, Busulfan, and Thiotepa as conditioning therapy

Sponsor

Sichuan University